Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?
- PMID: 31186119
- DOI: 10.1016/S0140-6736(19)31350-9
Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?
Comment on
-
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.Lancet. 2019 Jul 6;394(10192):39-50. doi: 10.1016/S0140-6736(19)31271-1. Epub 2019 Jun 8. Lancet. 2019. PMID: 31186120 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
